A comparison between protein profiles of B cell subpopulations and mantle cell lymphoma cells

Proteome Science

Volumn 7, Issue , 2009, Pages

  Stranneheim, Henrik ^a,b   Orre, Lukas M ^b   Lehtiö, Janne ^b   Flygare, Jenny ^b  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; IMMUNOGLOBULIN D;

ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CELL SELECTION; CONTROLLED STUDY; GERMINAL CENTER; HUMAN; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; LYMPHOMA CELL; MANTLE CELL LYMPHOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE STUDY; SEQUENCE HOMOLOGY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TONSIL;

EID: 71949127588     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-7-43     Document Type: Article

References (25)

1. Leich E, Hartmann EM, Burek C, Ott G, Rosenwald A. Diagnostic and prognostic significance of gene expression profiling in lymphomas. APMIS 2007, 115(10):1135-1146. 10.1111/j.1600-0463.2007.apm_867.xml.x, 18042147.
2. Lim MS, Elenitoba-Johnson KS. Mass spectrometry-based proteomic studies of human anaplastic large cell lymphoma. Mol Cell Proteomics 2006, 5(10):1787-1798. 10.1074/mcp.R600005-MCP200, 16785248.
3. Fan G, Molstad M, Braziel RM, Standley M, Huang J, Rodgers W, Nagalla S. Proteomic profiling of mature CD10+ B-cell lymphomas. Am J Clin Pathol 2005, 124(6):920-929. 10.1309/UEDXPHAAP740B61D, 16416742.
4. Jansen C, Hebeda KM, Linkels M, Grefte JM, Raemaekers JM, van Krieken JH, Groenen PJ. Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology. Cell Oncol 2008, 30(1):27-38.
5. Wright GL. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev Mol Diagn 2002, 2(6):549-563. 10.1586/14737159.2.6.549, 12465452.
6. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005, 5(4):251-262. 10.1038/nrc1589, 15803153.
7. Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007, 7(10):750-762. 10.1038/nrc2230, 17891190.
8. Bertoni F, Zucca E, Cotter FE. Molecular basis of mantle cell lymphoma. Br J Haematol 2004, 124(2):130-140. 10.1046/j.1365-2141.2003.04761.x, 14687022.
9. Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999, 341(20):1520-1529. 10.1056/NEJM199911113412007, 10559454.
10. Thorselius M, Walsh S, Eriksson I, Thunberg U, Johnson A, Backlin C, Enblad G, Sundstrom C, Roos G, Rosenquist R. Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol 2002, 68(4):217-224. 10.1034/j.1600-0609.2002.01662.x, 12071937.
11. Bertoni F, Ponzoni M. The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol 2007, 39(10):1747-1753. 10.1016/j.biocel.2007.04.026, 17574898.
12. Melo JV, Brito-Babapulle V, Foroni L, Robinson DS, Luzzatto L, Catovsky D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int J Cancer 1986, 38(4):531-538. 10.1002/ijc.2910380413, 3093393.
13. Melo JV, Foroni L, Brito-Babapulle V, Luzzatto L, Catovsky D. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement. Clin Exp Immunol 1988, 73(1):23-28. 1541467, 3262465.
14. Raynaud SD, Bekri S, Leroux D, Grosgeorge J, Klein B, Bastard C, Gaudray P, Simon MP. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chromosomes Cancer 1993, 8(2):80-87. 10.1002/gcc.2870080204, 7504521.
15. Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coiffier B, Bryon PA, Magaud JP. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994, 83(7):1871-1875.
16. Jadayel DM, Lukas J, Nacheva E, Bartkova J, Stranks G, De Schouwer PJ, Lens D, Bartek J, Dyer MJ, Kruger AR. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519). Leukemia 1997, 11(1):64-72. 10.1038/sj.leu.2400555, 9001420.
17. Drexler HG, MacLeod RA. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma. Leuk Res 2002, 26(9):781-787. 10.1016/S0145-2126(02)00026-7, 12127550.
18. Hurwitz R, Hozier J, LeBien T, Minowada J, Gajl-Peczalska K, Kubonishi I, Kersey J. Characterization of a leukemic cell line of the pre-B phenotype. Int J C ancer 1979, 23(2):174-180.
19. Pulvertaft JV. Cytology of Burkitt's Tumour (African Lymphoma). Lancet 1964, 1(7327):238-240. 10.1016/S0140-6736(64)92345-1, 14086209.
20. Nadkarni JS, Nadkarni JJ, Clifford P, Manolov G, Fenyo EM, Klein E. Characteristics of new cell lines derived from Burkitt lymphomas. Cancer 1969, 23(1):64-79. 10.1002/1097-0142(196901)23:1<64::AID-CNCR2820230107>3.0.CO;2-M, 4178827.
21. Eton O, Scheinberg DA, Houghton AN. Establishment and characterization of two human myeloma cell lines secreting kappa light chains. Leukemia 1989, 3(10):729-735.
22. Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk Res 2000, 24(8):681-703. 10.1016/S0145-2126(99)00195-2, 10936422.
23. Hutchens YT. New desorption strategies for the masss spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993, 576-580.
24. Ek S, Ortega E, Borrebaeck CA. Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma. Leuk Res 2005, 29(2):205-213. 10.1016/j.leukres.2004.06.009, 15607370.
25. Sandberg R, Ernberg I. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci USA 2005, 102(6):2052-2057. 10.1073/pnas.0408105102, 548538, 15671165.